Newly discovered RNA molecules hold promise for detecting and treating esophageal cancer

by Bill Lubinger,Case Western Reserve UniversityA hairpin loop from a pre-mRNA. Highlighted are the nucleobases (green) and the ribose-phosphate backbone (blue). Note that this is a single stran

Updated on: April 29,2024

Newly discovered RNA molecules hold promise for detecting and treating esophageal cancer

by Bill Lubinger,Case Western Reserve UniversityA hairpin loop from a pre-mRNA. Highlighted are the nucleobases (green) and the ribose-phosphate backbone (blue). Note that this is a single stran

Updated on:April 29,2024

Largest-ever atlas of normal breast cells brings unprecedented insights into mammary biology

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainA new study led by researchers at The University of Texas MD Anderson Cancer, University of California, Irvine

Updated on: February 24,2024

Largest-ever atlas of normal breast cells brings unprecedented insights into mammary biology

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainA new study led by researchers at The University of Texas MD Anderson Cancer, University of California, Irvine

Updated on:February 24,2024

Researchers report results in rare gynecologic cancers from DART immunotherapy trial

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainResults from the S1609 DART clinical trial, which tested an immunotherapy combination of ipilimumab plus nivolumab in 53 cohorts of pat

Updated on: February 03,2024

Researchers report results in rare gynecologic cancers from DART immunotherapy trial

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainResults from the S1609 DART clinical trial, which tested an immunotherapy combination of ipilimumab plus nivolumab in 53 cohorts of pat

Updated on:February 03,2024

Rogue immune cells linked to leukemia found to be a key driver of autoimmune diseases

by Garvan Institute of Medical ResearchA killer T cell (centre) hunting a target cell. Credit: NIH Image GalleryGene variants associated with leukemia can produce "rogue" immune cells t

Updated on: February 20,2024

Rogue immune cells linked to leukemia found to be a key driver of autoimmune diseases

by Garvan Institute of Medical ResearchA killer T cell (centre) hunting a target cell. Credit: NIH Image GalleryGene variants associated with leukemia can produce "rogue" immune cells t

Updated on:February 20,2024

Study validates first-ever predictive AI biomarker of androgen deprivation therapy benefit in prostate cancer

by University Hospitals Cleveland Medical CenterProstate cancer cells. Credit: NIH Image GalleryData from a new study published inNEJM Evidenceshows promise for personalized use of sh

Updated on: February 20,2024

Study validates first-ever predictive AI biomarker of androgen deprivation therapy benefit in prostate cancer

by University Hospitals Cleveland Medical CenterProstate cancer cells. Credit: NIH Image GalleryData from a new study published inNEJM Evidenceshows promise for personalized use of sh

Updated on:February 20,2024

Are the benefits of new cancer drugs worth the cost?

by Sbarro Health Research Organization (SHRO)The rate of growth in costs (red) vs. outcomes (green) of cancer care, is here expressed as the derivative D[fx0] of both functions (i.e.: the angular coef

Updated on: January 12,2024

Are the benefits of new cancer drugs worth the cost?

by Sbarro Health Research Organization (SHRO)The rate of growth in costs (red) vs. outcomes (green) of cancer care, is here expressed as the derivative D[fx0] of both functions (i.e.: the angular coef

Updated on:January 12,2024

Research shows PSMA PET/CT imaging changes management for close to 50% of prostate cancer patients

by Society of Nuclear Medicine and Molecular ImagingGraphical Abstract: Patients with detectable PSA (0.2-2.0 ng/mL) post-prostatectomy considered for salvage radiotherapy undergoing18F-DCFPyL P

Updated on: January 22,2024

Research shows PSMA PET/CT imaging changes management for close to 50% of prostate cancer patients

by Society of Nuclear Medicine and Molecular ImagingGraphical Abstract: Patients with detectable PSA (0.2-2.0 ng/mL) post-prostatectomy considered for salvage radiotherapy undergoing18F-DCFPyL P

Updated on:January 22,2024

New study shows more deaths with cancer as contributing cause during first year of pandemic

byAmerican Cancer SocietyACS research in Journal Oncology Practice. Credit: American Cancer SocietyIn a new study, American Cancer Society (ACS) researchers have discovered that deaths with canc

Updated on: January 12,2024

New study shows more deaths with cancer as contributing cause during first year of pandemic

byAmerican Cancer SocietyACS research in Journal Oncology Practice. Credit: American Cancer SocietyIn a new study, American Cancer Society (ACS) researchers have discovered that deaths with canc

Updated on:January 12,2024

Study confirms new prognostic markers for triple negative breast cancer

by SWOGCredit: CC0 Public DomainPhysicians who treat patients with triple negative breast cancer have two new ways to predict which patients may benefit most from the well-established post-surgery tre

Updated on: March 08,2024

Study confirms new prognostic markers for triple negative breast cancer

by SWOGCredit: CC0 Public DomainPhysicians who treat patients with triple negative breast cancer have two new ways to predict which patients may benefit most from the well-established post-surgery tre

Updated on:March 08,2024

Heart disease prevention is particularly important in cancer patients

by Johannes Angerer,Medical University of ViennaBaseline cardiovascular toxicity risk assessment checklist. BNP, B-type natriuretic peptide; cTn, cardiac troponin; CTR-CVT, cancer therapy-relate

Updated on: January 30,2024

Heart disease prevention is particularly important in cancer patients

by Johannes Angerer,Medical University of ViennaBaseline cardiovascular toxicity risk assessment checklist. BNP, B-type natriuretic peptide; cTn, cardiac troponin; CTR-CVT, cancer therapy-relate

Updated on:January 30,2024

Exercise associated with benefit to patients with advanced colorectal cancer

by Dana-Farber Cancer InstituteDr. Meyerhardt is the clinical director of the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute and the senior author of the study. Credit: Dana-Farbe

Updated on: May 05,2024

Exercise associated with benefit to patients with advanced colorectal cancer

by Dana-Farber Cancer InstituteDr. Meyerhardt is the clinical director of the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute and the senior author of the study. Credit: Dana-Farbe

Updated on:May 05,2024

Tumor-infiltrating lymphocyte therapy marks a milestone in cancer treatment, researchers say

byH. Lee Moffitt Cancer Center & Research InstituteCancer cell during cell division. Credit: National Institutes of HealthThe recent U.S. Food and Drug Administration approval of lifileucel,

Updated on: August 03,2024

Tumor-infiltrating lymphocyte therapy marks a milestone in cancer treatment, researchers say

byH. Lee Moffitt Cancer Center & Research InstituteCancer cell during cell division. Credit: National Institutes of HealthThe recent U.S. Food and Drug Administration approval of lifileucel,

Updated on:August 03,2024